+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Influenza Diagnostics Market 2023-2027

  • PDF Icon

    Report

  • 170 Pages
  • June 2023
  • Region: Global
  • TechNavio
  • ID: 5130921
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The influenza diagnostics market is forecasted to grow by USD 466.18 mn during 2022-2027, accelerating at a CAGR of 6.95% during the forecast period. The report on the influenza diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising incidence of influenza, growing demand for molecular diagnostics, and supportive government initiatives and funding.

The influenza diagnostics market is segmented as below:

By End-user

  • Hospitals and diagnostic laboratories
  • Academic and research centers
  • Homecare

By Type

  • Point-of-care testing
  • Immunodiagnostics
  • Molecular diagnostics

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the rising approvals for influenza diagnostic products as one of the prime reasons driving the influenza diagnostics market growth during the next few years. Also, the surge in a number of genetic characterization studies on the influenza virus and the rising adoption of rapid diagnostic products in physician office laboratories will lead to sizable demand in the market.

The report on the influenza diagnostics market covers the following areas:

  • Influenza diagnostics market sizing
  • Influenza diagnostics market forecast
  • Influenza diagnostics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading influenza diagnostics market vendors that include Abbott Laboratories, Becton Dickinson and Co., BICO Group AB, Bio Rad Laboratories Inc., Biocartis Group NV, bioMerieux SA, Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., Hologic Inc., Princeton BioMeditech Corp., QIAGEN NV, Response Biomedical Corp., SA Scientific Ltd., Sd Biosensor Inc., Sekisui Chemical Co. Ltd., Siemens Healthineers AG, Tecan Trading AG, Thermo Fisher Scientific Inc., and Quidelortho Corp.. Also, the influenza diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global Influenza Diagnostics Market 2023-2027 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global influenza diagnostics market 2023-2027 2017 - 2021 ($ million)
4.2 End-user Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
4.3 Type Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by End-user
6.1 Market segments
Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
6.2 Comparison by End-user
Exhibit 32: Chart on Comparison by End-user
Exhibit 33: Data Table on Comparison by End-user
6.3 Hospitals and diagnostic laboratories - Market size and forecast 2022-2027
Exhibit 34: Chart on Hospitals and diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Hospitals and diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Hospitals and diagnostic laboratories - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Hospitals and diagnostic laboratories - Year-over-year growth 2022-2027 (%)
6.4 Academic and research centers - Market size and forecast 2022-2027
Exhibit 38: Chart on Academic and research centers - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Academic and research centers - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Academic and research centers - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Academic and research centers - Year-over-year growth 2022-2027 (%)
6.5 Homecare - Market size and forecast 2022-2027
Exhibit 42: Chart on Homecare - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Homecare - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Homecare - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Homecare - Year-over-year growth 2022-2027 (%)
6.6 Market opportunity by End-user
Exhibit 46: Market opportunity by End-user ($ million)
Exhibit 47: Data Table on Market opportunity by End-user ($ million)
7 Market Segmentation by Type
7.1 Market segments
Exhibit 48: Chart on Type - Market share 2022-2027 (%)
Exhibit 49: Data Table on Type - Market share 2022-2027 (%)
7.2 Comparison by Type
Exhibit 50: Chart on Comparison by Type
Exhibit 51: Data Table on Comparison by Type
7.3 Point-of-care testing - Market size and forecast 2022-2027
Exhibit 52: Chart on Point-of-care testing - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Point-of-care testing - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Point-of-care testing - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Point-of-care testing - Year-over-year growth 2022-2027 (%)
7.4 Immunodiagnostics - Market size and forecast 2022-2027
Exhibit 56: Chart on Immunodiagnostics - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Immunodiagnostics - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Immunodiagnostics - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Immunodiagnostics - Year-over-year growth 2022-2027 (%)
7.5 Molecular diagnostics - Market size and forecast 2022-2027
Exhibit 60: Chart on Molecular diagnostics - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Data Table on Molecular diagnostics - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Chart on Molecular diagnostics - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Molecular diagnostics - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by Type
Exhibit 64: Market opportunity by Type ($ million)
Exhibit 65: Data Table on Market opportunity by Type ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 China - Market size and forecast 2022-2027
Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
9.9 Germany - Market size and forecast 2022-2027
Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.10 France - Market size and forecast 2022-2027
Exhibit 99: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on France - Year-over-year growth 2022-2027 (%)
9.11 Canada - Market size and forecast 2022-2027
Exhibit 103: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 104: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 105: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 107: Market opportunity By Geographical Landscape ($ million)
Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 115: Abbott Laboratories - Overview
Exhibit 116: Abbott Laboratories - Business segments
Exhibit 117: Abbott Laboratories - Key news
Exhibit 118: Abbott Laboratories - Key offerings
Exhibit 119: Abbott Laboratories - Segment focus
12.4 Becton Dickinson and Co.
Exhibit 120: Becton Dickinson and Co. - Overview
Exhibit 121: Becton Dickinson and Co. - Business segments
Exhibit 122: Becton Dickinson and Co. - Key news
Exhibit 123: Becton Dickinson and Co. - Key offerings
Exhibit 124: Becton Dickinson and Co. - Segment focus
12.5 BICO Group AB
Exhibit 125: BICO Group AB - Overview
Exhibit 126: BICO Group AB - Business segments
Exhibit 127: BICO Group AB - Key offerings
Exhibit 128: BICO Group AB - Segment focus
12.6 Bio Rad Laboratories Inc.
Exhibit 129: Bio Rad Laboratories Inc. - Overview
Exhibit 130: Bio Rad Laboratories Inc. - Business segments
Exhibit 131: Bio Rad Laboratories Inc. - Key news
Exhibit 132: Bio Rad Laboratories Inc. - Key offerings
Exhibit 133: Bio Rad Laboratories Inc. - Segment focus
12.7 Biocartis Group NV
Exhibit 134: Biocartis Group NV - Overview
Exhibit 135: Biocartis Group NV - Product/Service
Exhibit 136: Biocartis Group NV - Key offerings
12.8 bioMerieux SA
Exhibit 137: bioMerieux SA - Overview
Exhibit 138: bioMerieux SA - Product/Service
Exhibit 139: bioMerieux SA - Key offerings
12.9 Danaher Corp.
Exhibit 140: Danaher Corp. - Overview
Exhibit 141: Danaher Corp. - Business segments
Exhibit 142: Danaher Corp. - Key news
Exhibit 143: Danaher Corp. - Key offerings
Exhibit 144: Danaher Corp. - Segment focus
12.10 DiaSorin SpA
Exhibit 145: DiaSorin SpA - Overview
Exhibit 146: DiaSorin SpA - Business segments
Exhibit 147: DiaSorin SpA - Key news
Exhibit 148: DiaSorin SpA - Key offerings
Exhibit 149: DiaSorin SpA - Segment focus
12.11 F. Hoffmann La Roche Ltd.
Exhibit 150: F. Hoffmann La Roche Ltd. - Overview
Exhibit 151: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 152: F. Hoffmann La Roche Ltd. - Key news
Exhibit 153: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 154: F. Hoffmann La Roche Ltd. - Segment focus
12.12 Hologic Inc.
Exhibit 155: Hologic Inc. - Overview
Exhibit 156: Hologic Inc. - Business segments
Exhibit 157: Hologic Inc. - Key news
Exhibit 158: Hologic Inc. - Key offerings
Exhibit 159: Hologic Inc. - Segment focus
12.13 Princeton BioMeditech Corp.
Exhibit 160: Princeton BioMeditech Corp. - Overview
Exhibit 161: Princeton BioMeditech Corp. - Product/Service
Exhibit 162: Princeton BioMeditech Corp. - Key offerings
12.14 Quidelortho Corp.
Exhibit 163: Quidelortho Corp. - Overview
Exhibit 164: Quidelortho Corp. - Product/Service
Exhibit 165: Quidelortho Corp. - Key offerings
12.15 Sd Biosensor Inc.
Exhibit 166: Sd Biosensor Inc. - Overview
Exhibit 167: Sd Biosensor Inc. - Product/Service
Exhibit 168: Sd Biosensor Inc. - Key offerings
12.16 Siemens Healthineers AG
Exhibit 169: Siemens Healthineers AG - Overview
Exhibit 170: Siemens Healthineers AG - Business segments
Exhibit 171: Siemens Healthineers AG - Key news
Exhibit 172: Siemens Healthineers AG - Key offerings
Exhibit 173: Siemens Healthineers AG - Segment focus
12.17 Thermo Fisher Scientific Inc.
Exhibit 174: Thermo Fisher Scientific Inc. - Overview
Exhibit 175: Thermo Fisher Scientific Inc. - Business segments
Exhibit 176: Thermo Fisher Scientific Inc. - Key news
Exhibit 177: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 178: Thermo Fisher Scientific Inc. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 179: Inclusions checklist
Exhibit 180: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 181: Currency conversion rates for US$
13.4 Research methodology
Exhibit 182: Research methodology
Exhibit 183: Validation techniques employed for market sizing
Exhibit 184: Information sources
13.5 List of abbreviations
Exhibit 185: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 6: Executive Summary - Chart on Market Segmentation by Type
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on global influenza diagnostics market 2023-2027 2017 - 2021 ($ million)
Exhibits 19: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
Exhibits 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on End-user - Market share 2022-2027 (%)
Exhibits 31: Data Table on End-user - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by End-user
Exhibits 33: Data Table on Comparison by End-user
Exhibits 34: Chart on Hospitals and diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
Exhibits 35: Data Table on Hospitals and diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
Exhibits 36: Chart on Hospitals and diagnostic laboratories - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Hospitals and diagnostic laboratories - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Academic and research centers - Market size and forecast 2022-2027 ($ million)
Exhibits 39: Data Table on Academic and research centers - Market size and forecast 2022-2027 ($ million)
Exhibits 40: Chart on Academic and research centers - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Academic and research centers - Year-over-year growth 2022-2027 (%)
Exhibits 42: Chart on Homecare - Market size and forecast 2022-2027 ($ million)
Exhibits 43: Data Table on Homecare - Market size and forecast 2022-2027 ($ million)
Exhibits 44: Chart on Homecare - Year-over-year growth 2022-2027 (%)
Exhibits 45: Data Table on Homecare - Year-over-year growth 2022-2027 (%)
Exhibits 46: Market opportunity by End-user ($ million)
Exhibits 47: Data Table on Market opportunity by End-user ($ million)
Exhibits 48: Chart on Type - Market share 2022-2027 (%)
Exhibits 49: Data Table on Type - Market share 2022-2027 (%)
Exhibits 50: Chart on Comparison by Type
Exhibits 51: Data Table on Comparison by Type
Exhibits 52: Chart on Point-of-care testing - Market size and forecast 2022-2027 ($ million)
Exhibits 53: Data Table on Point-of-care testing - Market size and forecast 2022-2027 ($ million)
Exhibits 54: Chart on Point-of-care testing - Year-over-year growth 2022-2027 (%)
Exhibits 55: Data Table on Point-of-care testing - Year-over-year growth 2022-2027 (%)
Exhibits 56: Chart on Immunodiagnostics - Market size and forecast 2022-2027 ($ million)
Exhibits 57: Data Table on Immunodiagnostics - Market size and forecast 2022-2027 ($ million)
Exhibits 58: Chart on Immunodiagnostics - Year-over-year growth 2022-2027 (%)
Exhibits 59: Data Table on Immunodiagnostics - Year-over-year growth 2022-2027 (%)
Exhibits 60: Chart on Molecular diagnostics - Market size and forecast 2022-2027 ($ million)
Exhibits 61: Data Table on Molecular diagnostics - Market size and forecast 2022-2027 ($ million)
Exhibits 62: Chart on Molecular diagnostics - Year-over-year growth 2022-2027 (%)
Exhibits 63: Data Table on Molecular diagnostics - Year-over-year growth 2022-2027 (%)
Exhibits 64: Market opportunity by Type ($ million)
Exhibits 65: Data Table on Market opportunity by Type ($ million)
Exhibits 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 69: Chart on Geographic comparison
Exhibits 70: Data Table on Geographic comparison
Exhibits 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits 89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 90: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 91: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits 93: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits 94: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 99: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibits 100: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibits 101: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibits 102: Data Table on France - Year-over-year growth 2022-2027 (%)
Exhibits 103: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits 104: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits 105: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 106: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 107: Market opportunity By Geographical Landscape ($ million)
Exhibits 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 109: Impact of drivers and challenges in 2022 and 2027
Exhibits 110: Overview on Criticality of inputs and Factors of differentiation
Exhibits 111: Overview on factors of disruption
Exhibits 112: Impact of key risks on business
Exhibits 113: Vendors covered
Exhibits 114: Matrix on vendor position and classification
Exhibits 115: Abbott Laboratories - Overview
Exhibits 116: Abbott Laboratories - Business segments
Exhibits 117: Abbott Laboratories - Key news
Exhibits 118: Abbott Laboratories - Key offerings
Exhibits 119: Abbott Laboratories - Segment focus
Exhibits 120: Becton Dickinson and Co. - Overview
Exhibits 121: Becton Dickinson and Co. - Business segments
Exhibits 122: Becton Dickinson and Co. - Key news
Exhibits 123: Becton Dickinson and Co. - Key offerings
Exhibits 124: Becton Dickinson and Co. - Segment focus
Exhibits 125: BICO Group AB - Overview
Exhibits 126: BICO Group AB - Business segments
Exhibits 127: BICO Group AB - Key offerings
Exhibits 128: BICO Group AB - Segment focus
Exhibits 129: Bio Rad Laboratories Inc. - Overview
Exhibits 130: Bio Rad Laboratories Inc. - Business segments
Exhibits 131: Bio Rad Laboratories Inc. - Key news
Exhibits 132: Bio Rad Laboratories Inc. - Key offerings
Exhibits 133: Bio Rad Laboratories Inc. - Segment focus
Exhibits 134: Biocartis Group NV - Overview
Exhibits 135: Biocartis Group NV - Product/Service
Exhibits 136: Biocartis Group NV - Key offerings
Exhibits 137: bioMerieux SA - Overview
Exhibits 138: bioMerieux SA - Product/Service
Exhibits 139: bioMerieux SA - Key offerings
Exhibits 140: Danaher Corp. - Overview
Exhibits 141: Danaher Corp. - Business segments
Exhibits 142: Danaher Corp. - Key news
Exhibits 143: Danaher Corp. - Key offerings
Exhibits 144: Danaher Corp. - Segment focus
Exhibits 145: DiaSorin SpA - Overview
Exhibits 146: DiaSorin SpA - Business segments
Exhibits 147: DiaSorin SpA - Key news
Exhibits 148: DiaSorin SpA - Key offerings
Exhibits 149: DiaSorin SpA - Segment focus
Exhibits 150: F. Hoffmann La Roche Ltd. - Overview
Exhibits 151: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 152: F. Hoffmann La Roche Ltd. - Key news
Exhibits 153: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 154: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 155: Hologic Inc. - Overview
Exhibits 156: Hologic Inc. - Business segments
Exhibits 157: Hologic Inc. - Key news
Exhibits 158: Hologic Inc. - Key offerings
Exhibits 159: Hologic Inc. - Segment focus
Exhibits 160: Princeton BioMeditech Corp. - Overview
Exhibits 161: Princeton BioMeditech Corp. - Product/Service
Exhibits 162: Princeton BioMeditech Corp. - Key offerings
Exhibits 163: Quidelortho Corp. - Overview
Exhibits 164: Quidelortho Corp. - Product/Service
Exhibits 165: Quidelortho Corp. - Key offerings
Exhibits 166: Sd Biosensor Inc. - Overview
Exhibits 167: Sd Biosensor Inc. - Product/Service
Exhibits 168: Sd Biosensor Inc. - Key offerings
Exhibits 169: Siemens Healthineers AG - Overview
Exhibits 170: Siemens Healthineers AG - Business segments
Exhibits 171: Siemens Healthineers AG - Key news
Exhibits 172: Siemens Healthineers AG - Key offerings
Exhibits 173: Siemens Healthineers AG - Segment focus
Exhibits 174: Thermo Fisher Scientific Inc. - Overview
Exhibits 175: Thermo Fisher Scientific Inc. - Business segments
Exhibits 176: Thermo Fisher Scientific Inc. - Key news
Exhibits 177: Thermo Fisher Scientific Inc. - Key offerings
Exhibits 178: Thermo Fisher Scientific Inc. - Segment focus
Exhibits 179: Inclusions checklist
Exhibits 180: Exclusions checklist
Exhibits 181: Currency conversion rates for US$
Exhibits 182: Research methodology
Exhibits 183: Validation techniques employed for market sizing
Exhibits 184: Information sources
Exhibits 185: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global influenza diagnostics market: Abbott Laboratories, Becton Dickinson and Co., BICO Group AB, Bio Rad Laboratories Inc., Biocartis Group NV, bioMerieux SA, Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., Hologic Inc., Princeton BioMeditech Corp., QIAGEN NV, Response Biomedical Corp., SA Scientific Ltd., Sd Biosensor Inc., Sekisui Chemical Co. Ltd., Siemens Healthineers AG, Tecan Trading AG, Thermo Fisher Scientific Inc., and Quidelortho Corp..

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is rising approvals for influenza diagnostic products.'

According to the report, one of the major drivers for this market is the rising incidence of influenza.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Becton Dickinson and Co.
  • BICO Group AB
  • Bio Rad Laboratories Inc.
  • Biocartis Group NV
  • bioMerieux SA
  • Danaher Corp.
  • DiaSorin SpA
  • F. Hoffmann La Roche Ltd.
  • Hologic Inc.
  • Princeton BioMeditech Corp.
  • QIAGEN NV
  • Response Biomedical Corp.
  • SA Scientific Ltd.
  • Sd Biosensor Inc.
  • Sekisui Chemical Co. Ltd.
  • Siemens Healthineers AG
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • Quidelortho Corp.